| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS
Department of Neuroscience, Cell Biology, and Physiology, Wright State University Boonshoft School of Medicine, Dayton, Ohio
Submitted 31 October 2005 ; accepted in final form 1 April 2006
 |
ABSTRACT |
|---|
 TOP ABSTRACT METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
4%), PGE2 (30%) and PGE2 + CCh (60%). The IC50 of 4.0 µM implicated involvement of K+ channels other than KCa3.1. The secretory responses augmented by the K+ channel opener 1-EBIO were inhibited only at a high concentration of TRAM-34, suggesting further that KCa3.1 was not involved. Sensitivity of the synergistic response (PGE2 + CCh) to a high concentration TRAM-34 supported a requirement for multiple K+ conductive pathways in secretion. Clofilium (100 µM), a quaternary ammonium, inhibited Cl– secretory Isc and Gt activated by PGE2 (20%) but not K+ secretion activated by Epi. Thus Cl– secretion activated by physiological secretagogues occurred without apparent activity of KCa3.1 channels but was dependent on other types of K+ channels sensitive to high concentrations of TRAM-34 and/or clofilium. epinephrine; prostaglandin E2; cholinergic; Kcnn4; TRAM-34; clofilium
Secretion of Cl– and K+ in colonic epithelia is stimulated by various secretagogue substances (11, 14, 26, 37, 49). These responses can be grouped into the following three major modes based on Cl– and K+ secretory rate: modulatory, flushing, and synergistic (41). The modulatory mode consists of sustained electrogenic K+ secretion without sustained Cl– secretion, activated via adrenergic, prostanoid, and cholinergic pathways (7, 28, 44, 55). In contrast, the more familiar flushing mode exhibits both sustained Cl– and K+ secretion stimulated most commonly via prostanoid pathways (28, 49, 55). The highest rates of secretion are seen with the combined activation of prostanoid and cholinergic pathways, suggesting a synergistic interaction (8, 18, 76). This apparent regulatory synergism may result from the actions of cytosolic cAMP and Ca2+ to stimulate the K+ channels necessary for secretion (23, 47).
Several types of K+ channels have been detected in colonic epithelial cells (23, 40, 60, 71, 72). Two of these types have been proposed to support cAMP- and Ca2+-activated secretion, KV7.1 (KVLQT1, Kcnq1) and KCa3.1 (IK1, SK4, Kcnn4), respectively (23). Although other ion transport components of the secretory mechanism also are likely regulated, activation of both these K+ channel types would serve to permit the large rate of secretion observed during synergistic stimulation. A broader corollary of this idea would be that the secretory cells use a distinct set of K+ channel types in response to each secretagogue. The number of available K+ channel types is large (24, 39, 77), but likely only some of these would best serve the regulatory constraints needed for each activation mode. With the use of the specific inhibitor HMR-1556, KV7.1 was demonstrated to not play a crucial role in modulatory, flushing, or synergistic secretion (41). In particular, synergistic secretory activation was essentially independent of KV7.1 activation. The study reported here uses the selective inhibitor TRAM-34 to examine the involvement of KCa3.1 in these three secretory modes. The lower inhibitory specificity at high concentrations of TRAM-34 also allowed an examination of involvement by other K+ channel types.
|
METHODS |
|---|
|
TOPABSTRACTMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
20-cm-long segment ending roughly 5 cm from the border of the peritoneal cavity and in rats the 6-cm-long segment ending roughly 1 cm from the peritoneal border. Tissue fixation and immunolocalization. Colonic tissues were fixed after isolation, as described previously (41). Briefly, fixation was accomplished by pinning isolated mucosal sheets in a Sylgard-coated dish for immersion in fixation solutions (30–40 min, room temperature). These mucosal tissues were prepared for immunofluorescence by dehydration, sectioning, and mounting on gelatin-coated slides. Sections were permeabilized, blocked, and then incubated for 48 h (4°C) with primary antibody. A donkey anti-rabbit IgG antibody (Jackson ImmunoResearch Laboratories, West Grove PA), conjugated to fluorescein isothiocyanate, was used to detect immunoreactivity (15 ng/µl, 2 h, room temperature). Sections were washed and mounted in Vectashield (Vector Laboratories, Burlingame, CA), and fluorescence was visualized with an Olympus BX60 epifluorescence microscope. Dr. John B. Furness (University of Melbourne, Parkville, Australia) provided antiserum IK38/6 for the KCa3.1 K+ channel (residues 2–16 of rat Kcnn4), used at a 1:2,000 dilution for 48 h at 4°C (20). A peptide was generated with the identical sequence employed to produce antiserum IK38/6 (GGELVTGLGALRRRK; Genemed Synthesis, South San Francisco, CA), dissolved in water (0.6 mM), and used in controls of nonspecific interactions of antiserum IK38/6. Anti-KCa3.1 (residues 350–363 of rat Kcnn4) from Alomone Laboratories (Jerusalem, Israel) was used (1:200, 1:100, and 1:50 dilution) but did not produce any distinct labeling in guinea pig distal colonic mucosa. Detection of the KCa3.1 protein also was accomplished using immunoblotting (antiserum IK38/6 at a 1:5,000 dilution), as described previously (20, 41).
Transepithelial current measurement.
Isolated mucosal sheets were used for measurement of transepithelial current and conductance (28, 41). Four mucosal sheets from each animal were mounted in Ussing chambers (0.64 cm2 aperture), supported on the serosal face by Nuclepore filters (10 µm thick, 5 µm pore diameter; Whatman, Clifton, NJ). Bathing solutions (10 ml) were circulated by gas lift through water-jacketed reservoirs (37°C). Standard Ringer solution contained (in mM): 145 Na+, 5.0 K+, 2.0 Ca2+, 1.2 Mg2+, 125 Cl–, 25 HCO3–, 4.0 H2PO4–, and 10 D-glucose. Solutions were continually gassed with 95% O2 and 5% CO2, which maintained solution pH at 7.4. Chambers were connected to automatic voltage clamps (Physiologic Instruments, San Diego, CA) that permitted compensation for solution resistance and continuous measurement of short-circuit current (Isc). Transepithelial electrical potential difference (PD) was measured by paired calomel electrodes, current was passed across the tissue through two Ag-AgCl electrodes, and electrical connections to the chambers were made by Ringer-agar bridges. Isc was referred to as positive for cation flow across the epithelium from the mucosal-to-serosal side (Cl– secretion would produce a positive Isc and K+ secretion would produce a negative Isc). Transepithelial conductance (Gt) was calculated from currents produced by bipolar square voltage pulses imposed across the mucosa (±5 mV, 3-s duration, 1-min intervals).
A quiescent basal condition was induced by suppressing the neural and paracrine activators persisting in the isolated colonic mucosa (28, 41). The mucosal preparation removes influences from nerves in the underlying muscle layers such that only mucosal nerve endings remain which have only minimal contribution to the stimulation by secretagogues (6, 19, 28, 55). Indomethacin (2 µM) and the cyclooxygenase-2 inhibitor NS-398 (2 µM) were used to inhibit production of prostanoids within the isolated mucosa. Other compounds released from mucosal cells in the bathing solutions as a result of mucosal isolation were reduced in concentration (8,000-fold) by replacing the solutions three times, after mounting the mucosa in the chamber (28).
PGE2, indomethacin, and NS-398 were obtained from Cayman Chemical (Ann Arbor, MI), epinephrine from Elkins-Sinn (Cherry Hill, NJ), 1-EBIO from Tocris Bioscience (Ellisville, MO), and E-4031 from Wako Chemical (Richmond, VA). K+ channel inhibitor TRAM-34 {1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole} was provided by Dr. Heike Wulff (University of California, Davis, CA), and KV7 (KVLQT) inhibitor HMR-1556 {(3R,4S)-(+)-N-[3-hydroxy-2,2-dimethyl-6-(4,4,4-trifluorobutoxy)chroman-4-yl]-N-methyl-ethanesulfonamide} was provided by Dr. Uwe Gerlach (Aventis Pharma, Frankfurt am Main, Germany). All other chemicals, including clotrimazole and clofilium tosylate (4-chloro-N,N-diethyl-N-heptylbenzenebutanaminium tosylate), were obtained from Sigma Chemical (St. Louis, MO). Drugs were added in small volumes from concentrated stock solutions. PGE2 was prepared in an ethanol stock solution that added 0.03% ethanol at 3 µM of PGE2. TRAM-34 and clotrimazole were prepared in a DMSO stock solution (final added DMSO concentration of 0.2% at 100 µM of inhibitor). Stock solutions of HMR-1556 (10 mM) were made with DMSO. Additions of 1% ethanol or DMSO alone did not alter transepithelial measures of K+ or Cl– secretion (28).
Inhibitor-sensitive components of Isc and Gt were calculated using the paired responses of adjacent mucosal tissues. A nonlinear least-squares procedure was used to fit Henri-Michaelis-Menten binding curves to the responses of Isc and Gt to inhibitors (28, 41). Strip-chart recordings of Isc were digitized at 10-s intervals to examine secretory onset. Results are reported as means and SE. Statistical comparisons were made using a two-tailed Student's t-test for paired responses, with significant difference accepted at P < 0.05.
|
RESULTS |
|---|
|
TOPABSTRACTMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
Sensitivity of secretion to TRAM-34.
The KCa3.1 K+ channel (IK1, SK4, Kcnn4) is inhibited by TRAM-34, a derivative of clotrimazole (75). TRAM-34 inhibits KCa3.1 in human, mouse, and rat cells with an IC50 of 20 nM, but lacks the inhibitory action on P-450 enzymes of the parent compound clotrimazole (1, 3, 75). Both TRAM-34 and clotrimazole also inhibit a range of K+ channel types with IC50 values of 5 µM and higher so that specificity for KCa3.1 occurs only at a lower concentration. A concentration of 0.5 µM was chosen to provide 95% inhibition of KCa3.1 while only inhibiting other K+ channels by 10% or less. Similarly, concentrations of clotrimazole from 0.2 to 0.5 µM have been used to demonstrate specificity for KCa3.1 in cellular systems (36, 69). Because TRAM-34 is lipid soluble, inhibitory actions could occur at either basolateral or apical membranes regardless of the side of addition. Other lipophilic molecules (HMR-1556 and PGE2) as well have been delivered with high potency to colonic mucosa (28, 41).
TRAM-34 added to the serosal solution at 0.5 µM (Fig. 1) did not alter the response of guinea pig distal colonic mucosa to the modulatory secretagogue epinephrine or the flushing secretagogue PGE2, which supports a lack of involvement by KCa3.1 in these secretory responses. Mucosal addition produced similar results (data not shown). A similar lack of inhibition by 0.5 µM TRAM-34 was observed for secretory responses of the modulatory and flushing types in rat distal colonic mucosa (data not shown).
|
Inhibition by TRAM-34 at high concentration.
The lower specificity of TRAM-34 at high concentrations leads to inhibition of many K+ channels (75) such that 100 µM TRAM-34 would inhibit one group of channels by >90% (KV1.1, KV1.2, KV1.3, KV1.4, KV1.5/Kcna1–5, KV4.2/Kcnd2) and another group by 80% (KCa1.1/Kcnma1, KCa2.2, KCa2.3/Kcnn2–3, KV3.1/Kcnc1). TRAM-34 added at 100 µM produced a small reduction (<4%) of modulatory K+ secretion, suggesting only a minor inhibition of apical membrane K+ conductance (Fig. 2); TRAM-34 at 100 µM did not influence this modulatory response in rat distal colonic mucosa (data not shown). The apparent Cl– secretory rate during the flushing response was reduced substantially (30%) by high-concentration TRAM-34 (Fig. 2A), but the initial positive change in Isc also suggested a modest reduction of K+ secretion through inhibition of apical membrane K+ conductance followed by a larger influence on basolateral membrane K+ channels. Addition of TRAM-34 to the mucosal bath did not increase the apparent inhibition of the K+ secretory responses (data not shown). A similar inhibition of this flushing response by 100 µM TRAM-34 was observed in rat distal colonic mucosa (data not shown).
|
9%, P < 0.05) in the Isc stimulated during synergistic secretion (10 µM CCh added in the presence of 3 µM PGE2; 
Isc = –28.4 ± 7.0 µA/cm2, Gt = –0.84 ± 0.67 mS/cm2, n = 5), suggesting only a limited involvement of KCa3.1 in this secretory mode. However, TRAM-34 at high concentration markedly inhibited the synergistic response. Addition of CCh to ongoing flushing secretion (Fig. 3) stimulated a synergistic response largely resistant to TRAM-34 (100 µM) over the first 10 min followed by a progressive increase in TRAM-34-sensitive Isc over the next 30 min. Interestingly, the order of secretagogue activation influenced the time course of Isc increase (Figs. 3 and 4), unlike an earlier report (76). Stimulation by CCh before PGE2 addition dramatically reduced the TRAM-34-resistant Isc component of the synergistic response (Fig. 4A). The time course of the Gt response (Fig. 4, B and D) suggested the presence of an intricate compensatory reaction by the secretory cells. In addition, the modulatory response to CCh (Fig. 4, A and B) was unaltered by TRAM-34 at high concentration (100 µM), supporting a lack of involvement by KCa3.1 or any of several other K+ channel types. The IC50 for TRAM-34 inhibition of the synergistic response was 4.0 µM (Fig. 5), such that the minor inhibition seen at 0.5 µM (9%) likely was because of low-affinity inhibition of K+ channels other than KCa3.1. Clotrimazole produced similar results at both low and high concentrations (data not shown).
|
|
|
500 µM for 1-EBIO augmentation of the PGE2 response, a concentration of 300 µM was used to limit the possible influence of cAMP generation (15). Roughly, 1-EBIO appeared to convert the modulatory response of epinephrine into a flushing response consistent with sustained Cl– secretion and converted the flushing response of PGE2 into a synergistic-level response. The addition of CCh to these stimulated mucosae did not produce further increases in the electrogenic response, although changes in the time course of Isc and Gt suggested an alteration in the details of the secretory state that was attained.
|
|
|
Isc = 22.5 ± 11.7 µA/cm2, Gt = –2.05 ± 0.56 mS/cm2, n = 4). Clofilium inhibition of the PGE2 flushing response was statistically significant with a rapid component and a slowly developing decrease in Isc and Gt (Fig. 9). E-4031 (10 µM), an inhibitor of KV11 (erg, Kcnh2) and KV10 (eag, Kcnh1; see Refs. 13 and 21), did not alter the modulatory, flushing, or synergistic secretory responses when added to the mucosal or serosal bathing solution (data not shown).
|
Synergistic secretory response. The time course of synergistic stimulation in the presence of a high concentration TRAM-34 (Figs. 3 and 4) suggested that a similar steady-state condition could be attained through two distinct activation pathways. Comparison of the stimulation by PGE2 + CCh and CCh + PGE2 at higher time resolution (Fig. 10) illustrated these two routes for secretory onset. Cholinergic stimulation from ongoing flushing secretion (PGE2 + CCh) produced a large transient phase followed by a sustained phase (Fig. 10A), whereas the reversed order of stimulation (CCh + PGE2) produced primarily just the sustained phase (Fig. 10C). This diminution of the transient component coincided with the loss of the TRAM-34-resistant component (Fig. 10C), indicating that CCh inhibited the synergistic response by inhibiting K+ channels with little sensitivity to TRAM-34. Cholinergic stimulation (PGE2 + CCh) also activated a TRAM-34-sensitive Isc component with a relatively slow onset (Fig. 10A), but cholinergic induction of this Isc component apparently could occur without the need for channel activity, since with the CCh + PGE2 activation order TRAM-34-sensitive Isc maintained a steady, high level beginning immediately after PGE2 stimulation (Fig. 10C).
|
|
|
130 kDa (Fig. 13) was similar to that obtained from HEK-293 cells transfected with rat Kcnn4, which was interpreted as the assembled KCa3.1 tetramer (20). These results support further the presence of the KCa3.1 K+ channel protein in the colonic mucosa.
|
|
DISCUSSION |
|---|
|
TOPABSTRACTMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
In colonic epithelia, K+ channels are present in the apical and basolateral membrane so that the conductive K+ exit that acts to maintain Cl– secretion also can result in transepithelial K+ secretion (26, 36, 49, 71). An active absorptive process for K+ also is present in colonic epithelia such that net K+ transport is determined by a balance between secretory and absorptive activities (26, 49, 55). K+ absorption is driven by an apical membrane H+-K+ pump that operates by electroneutral exchange such that the transepithelial process also is electroneutral. Thus the active electrogenic K+ secretory rate can be measured separately from the active electroneutral K+ absorptive rate by using the Isc.
Role of KCa3.1 in colonic ion secretion. The presence of KCa3.1 (IK1, SK4, Kcnn4) in the colonic epithelium has been demonstrated by several experimental means. Most specifically, the mRNA for KCa3.1 has been observed by Northern blot analysis and RT-PCR in colonic epithelial cells from human, mouse, and rat (5, 12, 34, 35, 36, 67, 73). Immunoreactivity for KCa3.1 is present in the colonic mucosa of human (12) and rat (20, 36) and also was detected in guinea pig colonic mucosa (Figs. 12 and 13). The KCa3.1 immunoreactivity was present in the basolateral membrane of colonic epithelial cells at both surface and crypt locations (Refs. 20 and 36 and Fig. 12). Apical membrane KCa3.1 immunoreactivity was detected in crypt cells (Refs. 20 and 36 and Fig. 12C), whereas surface epithelial cell apical membranes of rat are immunoreactive (20) but those of guinea pig were negative (Fig. 12, A and B). Ca2+-activated K+ channel activity consistent with KCa3.1 also has been observed in the basolateral membrane of colonic crypt cells from human and rat (5, 60, 72).
Involvement of KCa3.1 in colonic ion secretion has been substantiated by stimulation of Ca2+-dependent K+ channel activity with secretagogues, but primarily by the sensitivity of secretion and KCa3.1 to inhibition by clotrimazole (23, 36, 50, 72). Use of clotrimazole for identifying KCa3.1 involvement is confounded by its equal potency at inhibiting P-450 enzymes and by inhibiting a range of K+ channels at concentrations higher than 1 µM (65, 75). In colonic epithelia, clotrimazole has been shown to be effective at inhibiting Cl– secretion only at high concentrations, which could include inhibitory action at several K+ channel types. The IC50 is 5 µM for clotrimazole inhibition of Cl– secretory Isc stimulated by CCh or vasoactive intestinal polypeptide (VIP) in the colonic tumor cell line T84 (57), suggesting dependence on K+ channels other than KCa3.1. Similarly, forskolin-stimulated Cl– secretory Isc in T84 cells has an IC50 of 5.2 µM for clotrimazole (17). Interestingly, the concentration-response curve for VIP-stimulated secretory Isc has a shape at low clotrimazole concentrations, suggesting a possible KCa3.1-dependent component of up to 20% of the total (57). Clotrimazole at 30 µM inhibits Cl– secretory Isc in human, rabbit, and rat distal colon (9, 45, 58, 73), which leaves unanswered the identity of the K+ channels involved. A study of rat proximal colon indicates that clotrimazole at 0.5 µM inhibits K+ secretion, apparently acting on apical membrane KCa3.1 K+ channels, since this concentration provides specificity among K+ channel types (36); however, the size of this K+ secretion is small, only 20% of the epinephrine-stimulated K+ secretory Isc in rat distal colon (41). Furthermore, cholinergic-stimulated K+ secretory Isc in human colon is insensitive to clotrimazole at 30 µM (46), similar to the result in guinea pig distal colon (Fig. 4A). Together with the results obtained using TRAM-34 in guinea pig (Fig. 1) and rat colon, the previous studies using clotrimazole suggest that the involvement of KCa3.1 in colonic secretion may be limited to a minor role.
The ability of the K+ channel opener 1-EBIO to activate KCa3.1 and colonic Cl– secretory Isc suggests involvement of KCa3.1 in the cellular mechanism for ion secretion (15, 16, 35, 62, 68). Interestingly, 1-EBIO did not stimulate secretory Isc from the basal state in guinea pig colon (Fig. 6), unlike murine colon and T84 cells (15, 16), which may have occurred because of the reduction of endogenous secretagogue substances in these guinea pig colon experiments. Although the EC50 for 1-EBIO activation of KCa3.1 is 60–80 µM (35, 62, 68), the 1-EBIO EC50 for stimulating secretion was approximately eightfold higher at 500–600 µM in murine colonic epithelia, T84 cells, and guinea pig distal colonic mucosa, supporting the possibility of additional actions for 1-EBIO in epithelial cells (15, 16). Clotrimazole inhibited the 1-EBIO-activated Cl– secretory Isc in T84 cells with an IC50 of 0.27 µM, suggestive of inhibition at KCa3.1 (17), whereas TRAM-34 was ineffective at 0.5 µM in guinea pig distal colonic mucosa (Fig. 7). The ability of TRAM-34 to inhibit 1-EBIO-augmented secretory Isc in guinea pig colon only at high concentration (Fig. 8) was consistent with inhibiting K+ channels other than KCa3.1 (75).
A role for KCa3.1 K+ channels in the function of colonic epithelia appears certain given the strong support for their presence in these cells (5, 12, 20, 34, 35, 36, 73). Contrary to the previous hypothesis (23), however, KCa3.1 would not appear to be one of the K+ channels involved in ion secretory responses, based on the inhibitory characteristics of TRAM-34 (Fig. 5). Of course, if KCa3.1 takes on a TRAM-34-insensitive character in colonic epithelia, then the inhibition observed at high concentration could include KCa3.1 activity. However, TRAM-34 inhibition of KCa3.1 activity does occur at concentrations <0.5 µM in several cell types, indicating that KCa3.1 in native cells from complex tissues retains sensitivity and that TRAM-34 can be delivered effectively to these cells during physiological measurements. In particular, cellular responses apparently dependent on KCa3.1, such as cytokine production in T lymphocytes and bactericidal peptide secretion in paneth cells, are sensitive to TRAM-34 at these low concentrations (1, 10, 75). Emerging evidence supports a role for KCa3.1 in epithelial cell volume control, including human intestinal cells and colonic crypt cells (59, 69). Mice lacking KCa3.1 (Kcnn4 null) have erythrocytes and T lymphocytes with severely impaired cell volume regulation but parotid salivary glands with normal rates of activated fluid secretion (4), which further supports the likelihood that KCa3.1 is not involved obligatorily in secretory responses.
Involvement of other K+ channels in colonic ion secretion.
In summary, modulatory K+ secretion stimulated by either epinephrine or CCh as well as flushing secretion stimulated by PGE2 and synergistic stimulation by the combination of PGE2 and CCh was not sensitive to inhibition by TRAM-34 at a concentration specific for KCa3.1 (Figs. 1 and 5). Because KCa3.1 was likely not required during these secretory modes, other K+ channel types must be involved in the responses. The inwardly rectified K+ channel observed in the basolateral membrane of guinea pig distal colonic crypts (with a single-channel conductance similar to KCa3.1) was stimulated by either forskolin or CCh but was insensitive to changes in Ca2+ activity on the cytoplasmic side contrary to the expectation for KCa3.1 (40); the molecular identity of this channel is presently unknown. The group of channels involved was defined further by sensitivity to the inhibitors clofilium and E-4031. Quaternary ammonium compounds have been extensively studied as inhibitors of K+ channels with tetraethylammonium+ (TEA+) as the archetypal example (32). Clofilium, an aromatic quaternary ammonium, inhibits K+ channels with higher affinity than TEA+ and has been suggested to have some specificity among the types of K+ channels, particularly KV1.5 (Kcna5), KV7.1 (KVLQT1, Kcnq1), KV10.1 (eag, Kcnh1), KV11.1 (erg, Kcnh2), and K2P5.1 (TASK-2, Kcnk5; see Refs. 13, 21, 22, 43, 52, 53, 61). The partial inhibition of flushing secretion by clofilium (Fig. 9) was unlikely the result of involvement by KV7.1, KV10.1, or KV11.1, since flushing secretion in guinea pig mucosa is insensitive to the KV7 inhibitor HMR-1556 (41) and was not inhibited by the KV11/KV10 inhibitor E-4031. Given the present extent of information on clofilium sensitivity, KV1.5 and K2P5.1 would remain as possible candidates for involvement in secretion. Because a high concentration TRAM-34 inhibited flushing secretion by only 30% (Fig. 2A), two classes of K+ channels at the least must be required to produce flushing secretion. The class of K+ channels sensitive to TRAM-34 at high concentration (75) includes KV1.1, KV1.2, KV1.3, KV1.4, KV1.5 (Kcna1–5), KV3.1 (Kcnc1), KV4.2 (Kcnd2), KCa1.1 (Kcnma1), KCa2.2, KCa2.3 (Kcnn2–3), and likely others that are presently untested. The larger TRAM-34-resistant component of secretory Isc could include any of the other K+ channel types, except KV7.1 and KCa3.1. Clearly, the K+ channel types needed for secretory responses in the colonic mucosa still remain ill defined.
Synergistic stimulation of colonic ion secretion. Secretion of Cl– and K+ across colonic epithelia is stimulated by a variety of secretagogues (11, 14, 26, 49, 72). The observation that a combination of secretagogues can produce more secretory Isc than expected from simple addition of the individual responses suggests a synergy within the intracellular signaling pathways (18, 70, 76). Because combinations of cAMP- and Ca2+-mobilizing agents reproduce the synergistic stimulation of secretory Isc, these two intracellular messengers are thought to produce the signaling interactions leading to synergistic stimulation (8, 48, 63, 70, 76). This concept of regulatory interaction fits within the more general synarchic (acting together) regulation observed for cAMP- and Ca2+-dependent cellular responses (54). The pattern in the colonic mucosa is one of redundant control in which both signals lead to the same ultimate response, but with elements of hierarchical control that has one signal potentiating the response to the other as well as antagonistic control between the signals. A commonly studied secretagogue pair is PGE2 and CCh, thought to represent cAMP and Ca2+ signaling, respectively. From a physiological perspective, CCh represents neural input and PGE2 represents the paracrine/autocrine regulation of immunomodulation (14, 37, 49).
The guinea pig distal colonic mucosa exhibits a large synergistic secretory Isc in response to stimulation by PGE2 and CCh (41, 56, 76) as well as by PGE2 and the tachykinin substance P (33). The robustness of the guinea pig secretory response allows for a fuller appreciation of all the facets of this synergistic control. For the colonic tumor cell line T84, synergism is most pronounced when PGE2 and CCh are added together or when CCh follows PGE2 addition (18, 63, 66). This dependence on the order of addition results from the additional antagonistic cholinergic control that inhibits the secretory Isc over a time course of 5–30 min (2, 38). In the guinea pig distal colonic mucosa, this cholinergic inhibition was apparent as a large transient component of the secretory Isc (Fig. 10A) that was nearly eliminated by pretreatment with CCh for 30 min (Fig. 10C). Importantly, in guinea pig colon, the synergistic secretory Isc response had a large component that was resistant to cholinergic inhibition, whereas T84 cells have mostly just the transient component.
Sensitivity of the synergistic response to a high concentration of TRAM-34 distinguished these same two components, with the transient component resistant to TRAM-34 inhibition and the steady-state component sensitive to TRAM-34 (Fig. 10, A and C). The TRAM-34-sensitive portion of the response included a brief transient phase during PGE2 + CCh addition (Fig. 10A). The slow time course of activation (
1/2 = 12.1 min) for the second TRAM-34-sensitive phase mirrored the time course of inhibition (1/2 = 11.9 min) for the resistant portion, suggesting that the cholinergic inhibition of TRAM-34-resistant K+ conductance was linked to this activation of a TRAM-34-sensistive K+ conductance. The nature of this activation was such that pretreatment with CCh resulted in a nearly immediate stimulation of the TRAM-34-sensitive portion upon PGE2 addition (Fig. 10C). The first and second phases may still have been present for CCh + PGE2 addition but simply merged because of overlap of activation and inactivation times. The candidate K+ channel types for this portion of the secretory Isc would be any with significant sensitivity to TRAM-34 at 100 µM (75), except for KV7.1 (41) and KCa3.1 (Fig. 5); the two TRAM-34-sensitive phases also could be different K+ channel types from within this class. The major distinction between the synergistic response in T84 cells and guinea pig colonic epithelial cells would be that T84 cells are much less capable of activating these TRAM-34-sensitive K+ channels to support secretion. The K+ channel types making up the K+ conductance during the transient component of synergistic stimulation found in both T84 cells and guinea pig colon cells would be any of the TRAM-34-resistant K+ channels. Overall, several separable groups of K+ channels appear to be activated to produce the distinctly different secretagogue-stimulated rates of ion secretion observed.
|
GRANTS |
|---|
|
TOPABSTRACTMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
|
ACKNOWLEDGMENTS |
|---|
|
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|
REFERENCES |
|---|
|
TOPABSTRACTMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
-defensin secretion by mIKCa1, a Ca2+-activated, intermediate conductance K+ channel. J Biol Chem 277: 3793–3800, 2002.2. Barrett KE and Keely SJ. Chloride secretion by the intestinal epithelium: Molecular basis and regulatory aspects. Annu Rev Physiol 62: 535–572, 2000.[CrossRef][Web of Science][Medline]
3. Beeton C, Wulff H, Barbaria J, Clot-Faybesse O, Pennington M, Bernard D, Cahalan MD, Chandy KG, and Beraud E. Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci USA 98: 13942–13947, 2001.
4. Begenisich T, Nakamoto T, Ovitt CE, Nehrke K, Brugnara C, Alper SL, and Melvin JE. Physiological roles of the intermediate conductance, Ca2+-activated K+ channel Kcnn4. J Biol Chem 279: 47681–47687, 2004.
5. Bowley KA, Morton MJ, Hunter M, and Sandle GI. Non-genomic regulation of intermediate conductance K+ channels by aldosterone in human colonic crypt cells. Gut 52: 854–860, 2003.
6. Bridges RJ, Rack M, Rummel W, and Schreiner J. Mucosal plexus and electrolyte transport across the rat colonic mucosa. J Physiol 376: 531–542, 1986.
7. Carew MA and Thorn P. Carbachol-stimulated Cl– secretion in mouse colon: evidence of a role for autocrine prostaglandin-E2 release. Exp Physiol 85: 67–72, 2000.[Abstract]
8. Cartwright CA, McRoberts JA, Mandel KG, and Dharmsathaphorn K. Synergistic action of cyclic adenosine monophosphate- and calcium-mediated Cl– secretion in a colonic epithelial cell line. J Clin Invest 76: 1837–1842, 1985.[Web of Science][Medline]
9. Cermak R, Kuhn G, and Wolffram S. The flavonol quercetin activates basolateral K+ channels in rat distal colon epithelium. Br J Pharm 135: 1183–1190, 2002.[CrossRef][Web of Science][Medline]
10. Chandy KG, Wulff H, Beeton C, Pennington M, Gutman GA, and Cahalan MD. K+ channels as targets for specific immunomodulation. Trends Pharm Sci 25: 280–289, 2004.[CrossRef][Medline]
11. Chang EB and Rao MC. Intestinal water and electrolyte transport: mechanisms of physiological and adaptive responses. Physiology of the Gastrointestinal Tract (3rd ed.), edited by Johnson LR, Alpers DH, Christensen J, and Jacobson ED. New York: Raven, 1994, vol. 1, p. 2027–2081.
12. Chen MX, Gorman SA, Benson B, Singh K, Hieble JP, Michel MC, Tate SN, and Trezise DJ. Small and intermediate conductance Ca2+-activated K+ channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum. Nauyn-Schmiedeberg's Arch Pharmacol 369: 602–615, 2004.[CrossRef][Web of Science][Medline]
13. Coetzee WA, Amarillo Y, Chiu J, Chow A, Lau D, McCormack T, Moreno H, Nadal MS, Ozaita A, Pountney D, Saganich M, De Miera EV, and Rudy B. Molecular diversity of K+ channels. Ann NY Acad Sci 868: 233–285, 1999.[CrossRef][Web of Science][Medline]
14. Cooke HJ and Reddix RA. Neural regulation of intestinal electrolyte transport. Physiology of the Gastrointestinal Tract (3rd ed.), edited by Johnson LR, Alpers DH, Christensen J, and Jacobson ED. New York: Raven, 1994, vol. 1, p. 2083–2132.
15. Cuthbert AW, Hickman ME, Thorn P, and MacVinish LJ. Activation of Ca2+- and cAMP-sensitive K+ channels in murine colonic epithelial by 1-ethyl-2-benzimidazolone. Am J Physiol Cell Physiol 277: C111–C120, 1999.
16. Devor DC, Singh AK, Frizzell RA, and Bridges RJ. Modulation of Cl– secretion by benzimidazolones. I. Direct activation of a Ca2+-dependent K+ channel. Am J Physiol Lung Cell Mol Physiol 271: L775–L784, 1996.
17. Devor DC, Singh AK, Gerlach AC, Frizzell RA, and Bridges RJ. Inhibition of intestinal Cl– secretion by clotrimazole: direct effect on basolateral membrane K+ channels. Am J Physiol Cell Physiol 273: C531–C540, 1997.
18. Dharmsathaphorn K and Pandol SJ. Mechanism of Cl– secretion induced by carbachol in a colonic epithelial cell line. J Clin Invest 77: 348–354, 1986.[Web of Science][Medline]
19. Diener M, Bridges RJ, Knobloch SF, and Rummel W. Neuronally mediated and direct effects of prostaglandins on ion transport in rat colon descendens. Nauyn-Schmiedeberg's Arch Pharmacol 337: 74–78, 1988.[Web of Science][Medline]
20. Furness JB, Robbins HL, Selmer IS, Hunne B, Chen MX, Hicks GA, Moore S, and Neylon CB. Expression of intermediate conductance K+ channel immunoreactivity in neurons and epithelial cells of the rat gastrointestinal tract. Cell Tissue Res 314: 179–189, 2003.[CrossRef][Web of Science][Medline]
21. Gessner G and Heinemann SH. Inhibition of hEAG1 and hERG1 K+ channels by clofilium and its tertiary analogue LY97241. Br J Pharm 138: 161–171, 2003.[CrossRef][Web of Science][Medline]
22. Gessner G, Zacharias M, Bechstedt S, Schönherr R, and Heinemann SH. Molecular determinants for high-affinity block of human EAG K+ channels by antiarrhythmic agents. Mol Pharm 65: 1120–1129, 2004.
23. Greger R, Bleich M, Riedemann N, van Driessche W, Ecke D, and Warth R. The role of K+ channels in colonic Cl– secretion. Comp Biochem Physiol 118A: 271–275, 1997.
24. Gutman GA, Chandy KG, Adelman JP, Aiyar J, Bayliss DA, Clapham DE, Covarriubias M, Desir GV, Furuichi K, Ganetzky B, Garcia ML, Grissmer S, Jan LY, Karschin A, Kim D, Kuperschmidt S, Kurachi Y, Lazdunski M, Lesage F, Lester HA, McKinnon D, Nichols CG, O'Kelly I, Robbins J, Robertson GA, Rudy B, Sanguinetti M, Seino S, Stuehmer W, Tamkun MM, Vandenberg CA, Wei A, Wulff H, and Wymore RS. International Union of Pharmacology. XLI Compendium of voltage-gated ion channels: potassium channels. Pharmacol Rev 55: 583–586, 2003.
25. Halm DR and Frizzell RA. Intestinal chloride secretion. In: Textbook of Secretory Diarrhea, edited by Lebenthal E and Duffey M. New York: Raven, 1990, p. 47–58.
26. Halm DR and Frizzell RA. Ion transport across the large intestine. Handbook of Physiology, The Gastrointestinal System, Intestinal Absorption and Secretion. Bethesda, MD: Am Physiol Soc, 1991, sect. 6, vol. IV, chapt. 8, p. 257–274.
27. Halm DR and Halm ST. Secretagogue response of goblet cells and columnar cells in human colonic crypts. Am J Physics Cell Physiol 277: C501–C522, 1999 (corrigenda 278: C212-C233, 2000).
28. Halm DR and Halm ST. Prostanoids stimulate K+ secretion and Cl– secretion in guinea pig distal colon via distinct pathways. Am J Physiol Gastrointest Liver Physiol 281: G984–G996, 2001.
29. Halm DR, Halm ST, DiBona DR, Frizzell RA, and Johnson RD. Selective stimulation of epithelial cells in colonic crypts: Relation to active Cl– secretion. Am J Physiol Cell Physiol 269: C929–C942, 1995.
30. Halm DR, Kirk KL, and Sathiakumar KC. Stimulation of Cl– permeability in colonic crypts of Lieberkühn measured with a fluorescent indicator. Am J Physiol Gastrointest Liver Physiol 265: G423–G431, 1993.
31. Halm DR and Rick R. Secretion of K+ and Cl– across colonic epithelium: Cellular localization using electron microprobe analysis. Am J Physiol Cell Physiol 262: C1001–C1011, 1992.
32. Hille B. Classical mechanisms of block. Ion Channels of Excitable Membranes (3rd ed.). Sunderland, MA: Sinauer, 2001, p. 503–537.
33. Hosoda Y, Karaki SI, Shimoda Y, and Kuwahara A. Substance P-evoked Cl– secretion in guinea pig distal colonic epithelia: Interaction with PGE2. Am J Physiol Gastrointest Liver Physiol 283: G347–G356, 2002.
34. Ishi TM, Silva C, Hirschberg B, Bond CT, Adelman JP, and Maylie J. A human intermediate conductance Ca2+-activated K+ channel. Proc Natl Acad Sci USA 94: 11651–11656, 1997.
35. Jensen BS, Strøbæk D, Christophersen P, Jørgensen TD, Hansen C, Silahtaroglu A, Olesen S, and Ahring PK. Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel. Am J Physiol Cell Physiol 275: C848–C856, 1998.
36. Joiner WJ, Basavappa S, Vidyasagar S, Nehrke K, Krishnan S, Binder HJ, Boulpaep EL, and Rajendran VM. Active K+ secretion occurs through multiple types of KCa channels and is regulated by IKCa channels in rat proximal colon. Am J Physiol Cell Physiol 285: C185–C196, 2003.
37. Karaki SI and Kuwahara A. Regulation of intestinal secretion involved in the interaction between neurotransmitters and prostaglandin E2. Neurogastroenterol Motil 16, Suppl 1: 96–99, 2004.[CrossRef]
38. Keely SJ and Barrett KE. Regulation of intestinal secretion involved in the interaction between neurotransmitters and prostaglandin E2. Ann NY Acad Sci 915: 67–76, 2000.[Web of Science][Medline]
39. Kubo Y. Overview of K+ channel families: molecular bases of the functional diversity. In: Handbook of Experimental Pharmacology. Pharmacology of Ionic Channel Function: Activators and Inhibitors, edited by Endo M, Kurachi Y, and Mishina M. Berlin: Springer, 2000, vol. 147, p. 157–176.
40. Li Y and Halm DR. Secretory modulation of basolateral membrane inwardly rectified K+ channel in guinea pig distal colonic crypts. Am J Physiol Cell Physiol 282: C719–C735, 2002.
41. Liao T, Wang L, Halm ST, Lu L, Fyffe REW, and Halm DR. K+ channel KVLQT (Kcnq1) located in the basolateral membrane of distal colonic epithelium is not essential for activating Cl– secretion. Am J Physiol Cell Physiol 289: C564–C575, 2005.
42. MacVinish LJ, Guo Y, Dixon AK, Murrell-Lagnado RD, and Cuthbert AW. XE991 reveals differences in K+ channels regulating Cl– secretion in murine airway and colonic epithelium. Mol Pharmacol 60: 753–760, 2001.
43. Malayev AA, Nelson DJ, and Philipson LH. Mechanism of clofilium block of the human KV1.5 delayed rectifier K+ channel. Mol Pharmacol 47: 198–205, 1995.[Abstract]
44. Mall M, Bleich M, Schürlein M, Kühr J, Seydewitz HH, Brandis M, Greger R, and Kunzelmann K. Cholinergic ion secretion in human colon requires coactivation of cAMP. Am J Physiol Gastrointest Liver Physiol 275: G1274–G1281, 1998.
45. Mall M, Gonska T, Thomas J, Hirtz S, Schreiber R, and Kunzelmann K. Activation of ion secretion via proteinase-activated receptor-2 in human colon. Am J Physiol Gastrointest Liver Physiol 282: G200–G210, 2002.
46. Mall M, Wissner A, Seydewitz HH, Kühr J, Brandis M, Greger R, and Kunzelmann K. Defective cholinergic Cl– secretion and detection of K+ secretion in rectal biopsies from cystic fibrosis patients. Am J Physiol Gastrointest Liver Physiol 278: G617–G624, 2000.
47. Mandel KG, McRoberts JA, Beuerlein G, Foster E, and Dharmsathaphorn K. Ba2+ inhibition of VIP- and A23187-stimulated Cl– secretion by T84 cell monolayers. Am J Physiol Cell Physiol 250: C486–C494, 1986.
48. Merlin D, Guo X, Laboisse CL, and Hopfer U. Ca2+ and cAMP activate different K+ conductances in the human intestinal goblet cell line HT29-C.16E. Am J Physiol Cell Physiol 268: C1503–C1511, 1995.
49. Montrose MH, Keely SJ, and Barrett KE. Electrolyte secretion and absorption: Small intestine and colon. Textbook of Gastroenterology (4th ed.), edited by Yamada T. Philadelphia, PA: Williams & Wilkins, 2003, p. 308–340.
50. Moschetta A, Portincasa P, Debellis L, Petruzzelli M, Montelli R, Calamita G, Gustavsson P, and Palasciano G. Basolateral Ca2+-dependent K+-channels play a key role in Cl– secretion induced by taurodeoxycholate from colon mucosa. Biol Cell 95: 115–122, 2003.[CrossRef][Web of Science][Medline]
51. Neylon CB, Nurgali K, Hunne B, Robbins HL, Moore S, Chen MX, and Furness JB. Intermediate-conductance calcium-activated K+ channels in enteric neurones of the mouse: pharmacological, molecular and immunochemical evidence for their role in mediating the slow afterhyperpolarization. J Neurochem 90: 1414–1422, 2004.[CrossRef][Web of Science][Medline]
52. Niemeyer MI, Cid LP, Barros LF, and Sepúlveda FV. Modulation of the two-pore domain acid-sensitive K+ channel TASK-2 (KCNK5) by changes in cell volume. J Biol Chem 276: 43166–43174, 2001.
53. Perry M, de Groot MJ, Helliwell R, Leishman D, Tristani-Firouzi M, Sanguinetti MC, and Mitcheson J. Structural determinants of HERG channel block by clofilium and ibutilide. Mol Pharmacol 66: 240–249, 2004.
54. Rasmussen H. Calcium and cAMP as Synarchic Messengers. New York: Wiley, 1981.
55. Rechkemmer G, Frizzell RA, and Halm DR. Active K+ transport across guinea pig distal colon: action of secretagogues. J Physiol 493: 485–502, 1996.
56. Rechkemmer G and von Engelhardt W. Absorption and secretion of electrolytes and short-chain fatty acids in the guinea pig large intestine. In: Ion Transport in Vertebrate Colon, edited by Clauss W. Berlin: Springer-Verlag, 1993, p. 139–167.
57. Rufo PA, Jiang L, Moe SJ, Brugnara C, Alper SL, and Lencer WI. The antifungal antibiotic, clotrimazole, inhibits Cl– secretion by polarized monolayers of human colonic epithelial cells. J Clin Invest 98: 2066–2075, 1996.[Web of Science][Medline]
58. Rufo PA, Merlin D, Riegler M, Ferguson-Maltzman MH, Dickinson BL, Brugnara C, Alper SL, and Lencer WI. The antifungal antibiotic, clotrimazole, inhibits Cl– secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances: demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera. J Clin Invest 100: 3111–3120, 1997.[Web of Science][Medline]
59. Sand P, Anger Å, and Rydqvist B. Hypotonic stress activates an intermediate conductance K+ channel in human colonic crypt cells. Acta Physiol Scand 182: 361–368, 2004.[CrossRef][Web of Science][Medline]
60. Sand P and Rydqvist B. The low conductance K+ channel in human colonic crypt cells has a voltage-dependent permeability not affected by Mg2+. Life Sci 71: 855–864, 2002.[CrossRef][Web of Science][Medline]
61. Suessbrich H, Schönherr R, Heinemann SH, Lang F, and Busch AE. Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241. FEBS Lett 414: 435–438, 1997.[CrossRef][Web of Science][Medline]
62. Syme CA, Gerlach AC, Singh AK, and Devor DC. Pharmacological activation of cloned intermediate- and small-conductance Ca2+-activated K+ channels. Am J Physiol Cell Physiol 278: C570–C581, 2000.
63. Tabcharani JA, Harris RA, Boucher A, Eng JWL, and Hanrahan JW. Basolateral K+ channel activated by carbachol in the epithelial cell line T84. J Membr Biol 142: 241–254, 1994.[Web of Science][Medline]
64. Thompson-Vest N, Shimizu Y, Hunne B, and Furness JB. The distribution of intermediate-conductance, calcium-activated K+ (IK) channels in epithelial cells. J Anat 208: 219–229, 2006.[CrossRef][Web of Science][Medline]
65. Unsöld B, Kerst G, Brousos H, Hübner M, Schreiber R, Nitschke R, Greger R, and Bleich M. KCNE1 reverses the response of the human K+ channel KCNQ1 to cytosolic pH changes and alters its pharmacology and sensitivity to temperature. Pfleügers Arch 441: 368–378, 2000.[CrossRef][Web of Science][Medline]
66. Vajanaphanich T, Schultz C, Tsien RY, Traynor-Kaplan AE, Pandol SJ, and Barrett KE. Cross-talk between Ca2+ and cAMP-dependent intracellular signaling pathways. J Clin Invest 96: 386–393, 1995.[Web of Science][Medline]
67. Vandorpe DH, Shmukler BE, Jiang L, Lim B, Maylie J, Adelman JP, de Franceschi L, Domenica Cappellinni M, Brugnara C, and Alper SL. cDNA cloning and functional characterization of the mouse Ca2+-gated K+ channel, mIK1. J Biol Chem 273: 21542–21553, 1998.
68. von Hahn T, Thiele I, Zingaro L, Hamm K, Garcia-Alzamora M, Köttgen M, Bleich M, and Warth R. Characterization of the rat SK4/IK1 K+ channel. Cell Physiol Biochem 11: 219–230, 2001.[CrossRef][Web of Science][Medline]
69. Wang J, Morishima S, and Okada Y. IK channels are involved in the regulatory volume decrease in human epithelial cells. Am J Physiol Cell Physiol 284: C77–C84, 2003.
70. Warhurst G, Higgs NB, Tonge A, and Turnberg LA. Stimulatory and inhibitory actions of carbachol on Cl– secretory responses in human colonic cell line T84. Am J Physiol Gastrointest Liver Physiol 261: G220–G228, 1991.
71. Warth R and Barhanin J. Function of K+ channels in the intestinal epithelium. J Memb Biol 193: 67–78, 2003.[CrossRef][Web of Science][Medline]
72. Warth R and Bleich M. K+ channels and colonic function. Rev Physiol Biochem Pharmcol 140: 1–62, 2000.
73. Warth R, Hamm K, Bleich M, Kunzelmann K, von Hahn T, Schreiber R, Ullrich E, Mengel M, Trautmann N, Kindle P, Schwab A, and Greger R. Molecular and functional characterization of the small Ca2+-regulated K+ channel (rSK4) of colonic crypts. Pflügers Arch 438: 437–444, 1999.[CrossRef][Web of Science][Medline]
74. Wulff H, Gutman GA, Cahalan MD, and Chandy KG. Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance Ca2+-activation K+ channel, IKCa1. J Biol Chem 276: 32040–32045, 2001.
75. Wulff H, Miller MJ, Hänsel W, Grissmer S, Cahalan MD, and Chandy KG. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci USA 97: 8151–8156, 2000.
76. Yajima T, Suzuki T, and Suzuki Y. Synergism between Ca2+-mediated and cyclic AMP-mediated activation of Cl– secretion in isolated guinea pig distal colon. Jpn J Physiol 38: 427–443, 1988.[Web of Science][Medline]
77. Yu FH and Catterall WA. The VGL-Chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis. Sci STKE 2004: rel5, 2004. [The data are available at www.stke.org/cgi/content/full/sigtrans;2004/253/rel5]
This article has been cited by other articles:
|
|
 |
|
  J. Zhang, S. T. Halm, and D. R. Halm Adrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: involvement of {beta}1- and {beta}2-adrenergic receptors Am J Physiol Gastrointest Liver Physiol, August 1, 2009; 297(2): G269 - G277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, S. T. Halm, and D. R. Halm Adrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: desensitization via the Y2-neuropeptide receptor Am J Physiol Gastrointest Liver Physiol, August 1, 2009; 297(2): G278 - G291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Gennari and W. J. Weise Acid-Base Disturbances in Gastrointestinal Disease Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1861 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Bajwa, A. Alioua, J. W. Lee, D. S. Straus, L. Toro, and C. Lytle Fenofibrate inhibits intestinal Cl secretion by blocking basolateral KCNQ1 K+ channels Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1288 - G1299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Flores, J. E. Melvin, C. D. Figueroa, and F. V. Sepulveda Abolition of Ca2+-mediated intestinal anion secretion and increased stool dehydration in mice lacking the intermediate conductance Ca2+-dependent K+ channel Kcnn4 J. Physiol., September 1, 2007; 583(2): 705 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. O'Mahony, R. Alzamora, V. Betts, F. LaPaix, D. Carter, M. Irnaten, and B. J. Harvey Female Gender-specific Inhibition of KCNQ1 Channels and Chloride Secretion by 17beta-Estradiol in Rat Distal Colonic Crypts J. Biol. Chem., August 24, 2007; 282(34): 24563 - 24573. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
Gt) had the prestimulation value subtracted (
, 10.3 mS/cm2; 
, 10.2 mS/cm2). TRAM-34 (0.5 µM) was added to the serosal bath (*) for an adjacent pair of mucosae either during stimulation by epinephrine (
20 nM) if the response depended only on KCa3.1 (
) for various K+ channels (
). TRAM-34 was present in treated mucosa 25 min before secretory activation. The half-times for Isc activation were 17.7 ± 1.4 s for control, 35.8 ± 2.5 s for the TRAM-34-resistant component, and 15.4 ± 2.3 s for the TRAM-34-sensitive component. The half-time for activation of the TRAM-34-resistant component was significantly longer than control (paired difference of 18.1 ± 2.7 s, P < 0.05). The TRAM-34-sensitive component also had a slow secondary activation with a half-time of 12.2 ± 1.1 min. The half-times for Isc inactivation were 11.9 ± 1.1 min for the TRAM-34-resistant component and 2.2 ± 0.6 min for the TRAM-34-sensitive component. Paired mucosae (n = 6) also were stimulated (as in 
